Luprolide

From OncoWiki
Jump to: navigation, search

Indication

Hormonal therapy for metastatic cancer

  • Luprolide (Lupron) 7.5 mg sc qm or 22.5 mg sc q3m


Drug Information

  • Trade Name: Lupron
  • Lupron is a hormone therapy. It is classified as an "LHRH agonist."


Drug Usage

  • Prostate cancer
  • Breast, ovarian and endometrial cancer
  • Also used in non-cancerous conditions such as endometriosis, infertility, benign prostatic hypertrophy (BPH).

References

Loblaw DA et al. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology Practice Guideline. J Clin Oncol 2007; 25:1596